Selective Inhibition of the Master Regulator Transcription Factor Egr‐1 With Catalytic Oligonucleotides Reduces Myocardial Injury and Improves Left Ventricular Systolic Function in a Preclinical Model of Myocardial Infarction

Selective Inhibition of the Master Regulator Transcription Factor Egr‐1 With Catalytic Oligonucleotides Reduces Myocardial Injury and Improves Left Ventricular Systolic Function in a Preclinical Model of Myocardial Infarction

Bibliographic Details
Main Authors: Rayner, Benjamin S., Figtree, Gemma A., Sabaretnam, Tharani, Shang, Ping, Mazhar, Jawad, Weaver, James C., Lay, William N., Witting, Paul K., Hunyor, Stephen N., Grieve, Stuart M., Khachigian, Levon M., Bhindi, Ravinay
Format: Online
Language:English
Published: Blackwell Publishing Ltd 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828787/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828787/

Similar Items